Nonadherence to beta blockers is a big issue with patients post-MI.
Although healthcare organizations have made great strides in boosting prescribing rates for beta blockers in patients who have suffered a myocardial infarction, (MI) data show that patients are not reaping the full value from these life-saving drugs. The problem is poor medication compliance. Experts maintain that providers and healthcare organizations should now turn their attention to this pressing problem.